Sheffield Asset Management’s Core Laboratories CLB Stock Holding History

Sheffield Asset Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-137,810	Closed	-$15.5M	–	15
2016 Q3	$15.5M	Buy	137,810 +400	+0.3%	+$46.1K	4.45%	11
2016 Q2	$17M	Sell	137,410 -74,600	-35%	-$9.01M	5.07%	11
2016 Q1	$23.8M	Buy	212,010 +2,900	+1%	+$301K	6.07%	9
2015 Q4	$22.7M	Hold	209,110	–	–	4.41%	14
2015 Q3	$20.9M	Buy	+209,110	New	+$22.7M	3.05%	15
2015 Q2	–	Sell	-278,900	Closed	-$29.1M	–	17
2015 Q1	$29.1M	Buy	+278,900	New	+$29.7M	4.56%	12

Other funds holding CLB

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Sheffield Asset Management's CLB Position: Q4 2016 in Review

Sheffield Asset Management sold out of Core Laboratories (CLB) in Q4 2016, closing a stake of 137,810 shares — an estimated $15.5M sold.

Sheffield Asset Management first reported a position in CLB in Q1 2015 and held it in 6 quarters. The position peaked at $29.1M in Q1 2015. 373 funds tracked by Wall St. Rank hold CLB as of Q4 2016.

Sheffield Asset Management reported no remaining Core Laboratories position as of Q4 2016 after selling out during the quarter.
Sheffield Asset Management sold 137,810 Core Laboratories shares in Q4 2016, an estimated $15.5M.
Sheffield Asset Management first reported a position in Core Laboratories in Q1 2015 and held it in 6 quarters.
Sheffield Asset Management's Core Laboratories position peaked at $29.1M in Q1 2015.
373 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2016.

Based on Sheffield Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.